Filter by patients with: All

What is ALS Phase 3 Study Ceftriaxone?

Category: Others

false

See also: Clinical Trial

NCT00349622 is a clinical trial with ceftriaxone in subjects with amyotrophic lateral sclerosis (ALS). Other study IDs include: U01NS049640-02, NINDS, U01NS049640-02, NINDS CRC.

See patients taking ALS Phase 3 Study Ceftriaxone

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Amyotrophic lateral sclerosis 13 24
Participate in clinical trial 10 12
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 28 patients that have used ALS Phase 3 Study Ceftriaxone

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 2
Moderate 11
Mild 6
None 15

Commonly reported side effects and conditions associated with ALS Phase 3 Study Ceftriaxone

Side effect Patients Percentage
Gallstones 3
Acid reflux 1
Candida (fungal) infection 1
Diarrhea 1
Fever 1
Flank pain 1

Show all 10 reported side effects

Why patients stopped taking ALS Phase 3 Study Ceftriaxone

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 4
Side effects too severe 4
Doctor's advice 3
Other 2
Did not seem to work 1
See all 11 patients who've stopped using ALS Phase 3 Study Ceftriaxone

Duration

Stopped using ALS Phase 3 Study Ceftriaxone

Duration Patients Percentage
Less than 1 month 2
6 months - 1 year 2
1 - 2 years 6
2 - 5 years 1
Adherence
Adherence Evaluations Percentage
Always 29
Usually 3
Sometimes 0
Never taken as prescribed 2
Burden
Burden Evaluations Percentage
Very hard to take 6
Somewhat hard to take 17
A little hard to take 9
Not at all hard to take 2
Cost per month
Cost per month Evaluations Percentage
$200+ 3
$100-199 0
$50-99 0
$25-49 0
< $25 22
Not specified 9
Last updated:

2 patient evaluations for ALS Phase 3 Study Ceftriaxone

Sort by: Most recent

Apr 29, 2011 (Started Oct 22, 2010)

  • Effectiveness
    Can't tell (for amyotrophic lateral sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1 other Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

Mar 4, 2011 (Started Oct 22, 2010)

  • Effectiveness
    Can't tell (for amyotrophic lateral sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 1 other Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly
  • 0 helpful marks

Dec 20, 2010 (Started Oct 11, 2010)

  • Effectiveness
    Can't tell (for Participate in clinical trial)
  • Side effects
    Mild (itching and rash from patch adhesive, lymphocytopenia (low lymphocytes))
  • Adherence
    Usually
  • Burden
    Somewhat hard to take
Dosage: 2 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly
Side effects: lymphocytopenia (low lymphocytes), itching and rash from patch adhesive

Nov 20, 2010 (Started Oct 11, 2010)

  • Effectiveness
    None (for Participate in clinical trial)
  • Side effects
    Moderate (itching and rash from patch adhesive, lymphocytopenia (low lymphocytes))
  • Adherence
    Usually
  • Burden
    Somewhat hard to take
Dosage: 2 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly
Side effects: lymphocytopenia (low lymphocytes), itching and rash from patch adhesive

Oct 21, 2010 (Started Oct 11, 2010)

  • Effectiveness
    Can't tell (for Participate in clinical trial)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 4 g Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly
Side effects: lymphocytopenia (low lymphocytes), itching and rash from patch adhesive
  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for ALS Phase 3 Study Ceftriaxone